IL-22 Enhances CCL20 Production in IL-1β-Stimulated Human Gingival Fibroblasts

Inflammation

Volumn 37, Issue 6, 2014, Pages 2062-2066

  Hosokawa, Yoshitaka ^a   Hosokawa, Ikuko ^a   Shindo, Satoru ^a   Ozaki, Kazumi ^a   Matsuo, Takashi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

CCL20; human gingival fibroblasts; IL 1 ; IL 22

Indexed keywords

CCL20 PROTEIN, HUMAN; INTERLEUKIN 1BETA; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA;

BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; DRUG POTENTIATION; FIBROBLAST; GINGIVA; HUMAN; METABOLISM;

CELLS, CULTURED; CHEMOKINE CCL20; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FIBROBLASTS; GINGIVA; HUMANS; INTERLEUKIN-1BETA; INTERLEUKINS;

EID: 84937557635     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9939-5     Document Type: Article

References (16)

1. Taubman, M.A., and T. Kawai. 2001. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Critical Reviews in Oral Biology and Medicine 12: 125–135.
2. Afar, B., D. Engel, and E.A. Clark. 1992. Activated lymphocyte subsets in adult periodontitis. Journal of Periodontal Research 27: 126–133.
3. Lappin, D.F., O. Koulouri, M. Radvar, P. Hodge, and D.F. Kinane. 1999. Relative proportions of mononuclear cell types in periodontal lesions analyzed by immunohistochemistry. Journal of Clinical Periodontology 26: 183–189.
4. Kawai, T., T. Matsuyama, Y. Hosokawa, S. Makihira, M. Seki, N.Y. Karimbux, R.B. Goncalves, P. Valverde, S. Dibart, Y.P. Li, L.A. Miranda, C.W. Ernst, Y. Izumi, and M.A. Taubman. 2006. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. American Journal of Pathology 169: 987–998.
5. Han, X., T. Kawai, J.W. Eastcott, and M.A. Taubman. 2006. Bacterial-responsive B lymphocytes induce periodontal bone resorption. Journal of Immunology 176: 625–631.
6. Gaffen, S.L., and G. Hajishengallis. 2008. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. Journal of Dental Research 87: 817–828.
7. Hirota, K., H. Yoshitomi, M. Hashimoto, S. Maeda, S. Teradaira, N. Sugimoto, T. Yamaguchi, T. Nomura, H. Ito, T. Nakamura, N. Sakaguchi, and S. Sakaguchi. 2007. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. Journal of Experimental Medicine 204: 2803–2812.
8. Hosokawa, Y., I. Hosokawa, K. Ozaki, H. Nakae, and T. Matsuo. 2005. Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin. Clinical and Experimental Immunology 142: 285–291.
9. Hosokawa, Y., I. Hosokawa, K. Ozaki, H. Nakae, and T. Matsuo. 2012. Interleukin (IL)-17A synergistically enhances CC chemokine ligand 20 production in IL-1β-stimulated human gingival fibroblasts. Human Immunology 73: 26–30.
10. Liang, S.C., X.Y. Tan, D.P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L.A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. Journal of Experimental Medicine 203: 2271–2279.
11. Kotenko, S.V., L.S. Izotova, O.V. Mirochnitchenko, E. Esterova, H. Dickensheets, R.P. Donnelly, and S. Pestka. 2001. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. Journal of Biological Chemistry 276: 2725–2732.
12. Marijnissen, R.J., M.I. Koenders, R.L. Smeets, M.H. Stappers, C. Nickerson-Nutter, L.A. Joosten, A.M. Boots, and W.B. van den Berg. 2011. Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation. Arthritis and Rheumatism 63: 2939–2948.
13. Hughes, T., B. Becknell, A.G. Freud, S. McClory, E. Briercheck, J. Yu, C. Mao, C. Giovenzana, G. Nuovo, L. Wei, X. Zhang, M.A. Gavrilin, M.D. Wewers, and M.A. Caligiuri. 2010. Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity 32: 803–814.
14. Ikeuchi, H., T. Kuroiwa, N. Hiramatsu, Y. Kaneko, K. Hiromura, K. Ueki, and Y. Nojima. 2005. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis and Rheumatism 52: 1037–1046.
15. Lejeune, D., L. Dumoutier, S. Constantinescu, W. Kruijer, J.J. Schuringa, and J.C. Renauld. 2002. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. Journal of Biological Chemistry 277: 33676–33682.
16. Andoh, A., Z. Zhang, O. Inatomi, S. Fujino, Y. Deguchi, Y. Araki, T. Tsujikawa, K. Kitoh, S. Kim-Mitsuyama, A. Takayanagi, N. Shimizu, and Y. Fujiyama. 2005. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129: 969–984.